Lift ban on fish from Karnataka or face ban from us too: UTK warns Goa

Bengaluru, Mar 2: The Karnataka Department of Public Instruction has directed the School heads across the State to grant leave to students and staff suffering from fever, cold, cough and other respiratory infections.

As precautionary measure following the COVID-19 (known as coronavirus) outbreak at the global level, the department issued a circular in this regard here on Monday.

If any student, teacher or staff is suffering from respiratory infections, they should be granted leave. They should be allowed to come back to school only after confirming from the doctor that they are cured, the circular added.

Udupi, Jan 16: Admar Mutt Junior seer Eshapriya Theertha Swami is all set to take over the reins of Krishna Mutt during the 250th Paryayotsava, scheduled to be held on January 17 and 18.

The uniqueness lies in the fact that the Admar Mutt, one of the Ashta Mutts of Krishna Mutt in this Temple town Udupi, ushers in the new Paryaya cycle (32nd). The Paryaya of outgoing seer Vidyadheesha Theertha Swami of Palimaru Mutt, Admar’s dwandwa (associate) mutt, marks the end of the cycle of eight mutts.

Under the system initiated by the Madhwa philosopher and saint Madwacharya, the seers of Ashta mutts would take turns to worship Lord Krishna every two months. Seer Vadiraja (1481-1601) ended the system and introduced the system of f running the temple administration once in two years.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.